AST-201

· Aptamer Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AST-201, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors [Phase 1]

See pricing